Analysis of IL-2, IFN-γ and TNF-α production, α5 β1 integrins and actin filaments distribution in peritoneal mouse macrophages treated with homeopathic medicament

Journal of Submicroscopic Cytology and Pathology

Volumn 34, Issue 3, 2002, Pages 255-263

  Da Rocha Piemonte, M ^a   De Freitas Buchi, D ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Fibronectin; Integrin; Interferon ; Interleukin 2; Macrophage; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; HOMEOPATHIC AGENT; INTERLEUKIN 2; METODO CANOVA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5; CYTOKINE; IMMUNOLOGICAL ADJUVANT; MATERIA MEDICA;

ACTIN FILAMENT; ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CELL CULTURE; CELL INTERACTION; CELL ORGANELLE; CELL VOLUME; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; LABORATORY; MICROMORPHOLOGY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SUPERNATANT; TECHNIQUE; ANIMAL; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECT; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MICROFILAMENT; PATHOLOGY;

ANIMALIA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTEGRIN ALPHA5BETA1; INTERFERON TYPE II; INTERLEUKIN-2; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MATERIA MEDICA; MICE; MICROFILAMENTS; MICROSCOPY, CONFOCAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036652194     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BALKWILL F.R., 1989. Interferons. Lancet, 1, 1060-1063.
2. BALLOW M. and NELSON R., 1997. Immunopharmacology - Immunomodulation and immunotherapy. JAMA, 278 (22), 2008-2017.
3. FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell Biol., 119, 893-903.
4. CHEN H., KINZER C.A. and PAUL W.E., 1996. p161, a murine membrane protein expressed on mast cells and some macrophages, is mouse CD13/aminopeptidase N. J. Immunol., 157 (6), 2593-2600.
5. CLARK R.A.F., LANIGAN J.M., DELLAPELLE P., MANSEAU E., DVORAK H.F. and COLVIN R.B., 1982. Fibronectin and fibrin provide a provisional matrix for experimental cell migration during wound reepithelialization. J. Invest. Dermatol., 79, 264-269.
6. DARRIBERE T., KOTELIANSKY V.E., CHERNOUSOV M.A., AKIYAMA S.K., YAMADA K.M., THIERY J.P. and BOUCAUT J.C., 1992. Distinct regions of human fibronectin are essential for fibril assembly in in vivo developing system. Dev. Dynam., 194, 63-70.
7. DASH D., AEPFELBACHER M. and SIESS W., 1995. The association of pp 125 fak, pp60 src, CDC42Hs and Rap1B with the cytoskeleton of aggregated platelets is a reversible process regulated by calcium. FEBS Lett., 363, 231-234.
8. DINARELLO C.A., GELFAND J.A. and WOLFF S.M., 1993. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA, 269, 1829-1835.
9. DORR R.T., 1993. Interferon-α in malignant and viral diseases. Drugs, 45, 177-211.
10. ERWING L.P., KLUTH D.C., WALSH G.M. and REESA A.J., 1998. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J. Immunol., 11, 1983-1988.
11. EVANS R.D., ARGILÉS J.M. and WILLLAMSON D.H., 1989. Metabolic effects of tumour necrosis factor-α (cachectin) and interleukin-1. Clin. Sci., 77, 357-364.
12. FARRAR M.A. and SCHREIBER R.D., 1983. The molecular cell biology of interferon-gamma and its receptor. Ann. Ver. Immunol., 11, 571-611.
13. GRIMELL F., 1978. Cellular adhesiveness and extracellular substrata. Int. Ver. Cytol., 53, 65-144.
14. HYNES R.O., 1992. Integrin: versatility, modulation, and signalling in cell adhesion. Cell, 69, 11-25.
15. KENNY A.J., O'HARE M.J. and GUSTERSON B.A., 1989. Cell-surface peptidases as modulators of growth and differentiation. Lancet, 2, 785.
16. neg mast cells in mouse bone marrow cell cultures. Use of a monoclonal anti-p161 antibody. J. Exp. Med., 182, 575-579.
17. 1) mRNA expression in human monocytes and monocytes-derived macrophages by activation/differentiation signals. Exp. Hematol., 19, 653-658.
18. KOHN E.C., ALESSANDRO R., SPOONSTER J., WERSTO R.P. and LIOTTA L.A., 1995. Angiogenesis: role of calcium-mediated signal transduction. Proc. Natl. Acad. Sci., 92, 1307-1311.
19. KURZROCK R., GUTTERMAN J.U. and TALPAZ M., 1991. Interferons-α, β, γ: basic principles and preclinical studies. In: 'Biologic Therapy of Cancer'. De Vita Jr. V.T., Hellman S. and Rosenberg S.A. eds., J.B. Lippincott Company, Philadelphia, pp. 247-274.
20. NATHAN C.J., ARRICK B.A., MURRAY H.W., DE SANTIS N.M. and COHN Z.A., 1980. Tumor cell anti-oxidant defenses. Inhibitor of the glutamine redox cycle enhances macrophage-mediated cytolysis. J. Exp. Med, 153, 766-782.
21. PEPPELENBOSCH M., BOONE E., JONES G.E., VAN DEVENTER S.J.H., HAEGEMAN G., FIERS W., GROOTEN J. and RIDLEY A.J., 1999. Multiple signal transduction pathways regulate TNF-induced actin reorganization in macrophages: inhibition of Cdc42-mediated filopodium formation by TNF. J. Immunol., 162, 837-845.
22. POMMIER C.G., INADA S., FRIES F. et al., 1983. Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes. J. Exp. Med., 157, 1844.
23. ROSENBERG S., LOTZE M. and MUUL L., 1985. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med., 313, 1485-1492.
24. STEIN M. and GORDON S., 1991. Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: role of cell stimulation and specific phagocytic plasma membrane receptors. Eur. J Immunol., 21 (2), 431-437.
25. SUZUKI T., 1991. Signal transduction mechanisms through Fcγ receptors on the mouse macrophage surface. FASEB J., 5, 187-193.
26. UNANUE E.R., 1989. Macrophages, antigen-presenting cells, and the phenomena of antigen handling and presentation. In: 'Fundamental Immunology'. Paul W. E. ed., Raven Press, New York, 2nd ed., pp. 95-115.
27. VAN HAL P.T.W., HOPSTAKEN-BROOS J.P.M., WIJKHUIJS J.M., TE VELDE A.A., FIGDOR C.G. and HOOGSTEDEN H.C., 1992. Regulation of aminopeptidase-N (CD13) and (CD23) expression by IL-4 depends on the stage of maturation of monocytes/macrophages. J. Immunol., 149 (4), 1395-1401.
28. WOJCIAK-STOTHARD B., DENYER M., MISHIRA M. and BROWN R.A., 1997. Adhesion, orientation, and movement of cells cultured on ultrathin fibronectin fibers. In Vitro Cell. Dev. Biol., 33, 110-117.
29. WRIGHT S.D. and MEYER B.C., 1985. Fibronectin receptors of human macrophages recognize the sequence arg-gly-asp-ser. J. Exp Med, 162, 762.